Juncture Wealth Strategies LLC lessened its stake in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 2.2% during the 2nd quarter, according to its most recent disclosure with the SEC. The institutional investor owned 39,474 shares of the biopharmaceutical company’s stock after selling 908 shares during the quarter. Juncture Wealth Strategies LLC’s holdings in Catalyst […]
Livforsakringsbolaget Skandia Omsesidigt increased its position in shares of Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 47.8% in the first quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 82,300 shares of the biopharmaceutical company’s stock after purchasing an additional 26,600 shares during the quarter. […]
Texas Permanent School Fund Corp grew its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Free Report) by 35.4% during the first quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 82,297 shares of the biopharmaceutical company’s stock after acquiring an additional 21,497 shares during the […]
O Neil Global Advisors Inc. lifted its holdings in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 18.1% during the 1st quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 29,343 shares of the biopharmaceutical company’s stock after purchasing an additional 4,505 shares during the period. […]
Renaissance Technologies LLC decreased its position in Catalyst Pharmaceuticals, Inc. (NASDAQ:CPRX – Get Rating) by 44.7% in the 4th quarter, HoldingsChannel reports. The institutional investor owned 1,231,512 shares of the biopharmaceutical company’s stock after selling 995,000 shares during the quarter. Renaissance Technologies LLC’s holdings in Catalyst Pharmaceuticals were worth $22,906,000 as of its most recent […]